Aurealis Pharma is a biopharmaceutical company.
Aurealis Pharma has raised €6.9M across 1 funding round from 1 investor, most recently a Series B round in Jan 2019. Based in Kuopio, Finland; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series B |
| €6.9M |
| Finnvera Venture Capital |
| View deal → |
